HomeCompareCMAXW vs EPRT

CMAXW vs EPRT: Dividend Comparison 2026

CMAXW yields 20833.33% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMAXW wins by $78708720625850728448.00M in total portfolio value
10 years
CMAXW
CMAXW
● Live price
20833.33%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78708720625850728448.00M
Annual income
$77,972,479,019,762,930,000,000,000.00
Full CMAXW calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — CMAXW vs EPRT

📍 CMAXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMAXWEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMAXW + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMAXW pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMAXW
Annual income on $10K today (after 15% tax)
$1,770,833.33/yr
After 10yr DRIP, annual income (after tax)
$66,276,607,166,798,485,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, CMAXW beats the other by $66,276,607,166,798,485,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMAXW + EPRT for your $10,000?

CMAXW: 50%EPRT: 50%
100% EPRT50/50100% CMAXW
Portfolio after 10yr
$39354360312925364224.00M
Annual income
$38,986,239,509,881,460,000,000,000.00/yr
Blended yield
99.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

CMAXW
No analyst data
Altman Z
-7.4
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMAXW buys
0
EPRT buys
0
No recent congressional trades found for CMAXW or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMAXWEPRT
Forward yield20833.33%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$78708720625850728448.00M$63.4K
Annual income after 10y$77,972,479,019,762,930,000,000,000.00$12,840.73
Total dividends collected$78660158496375930880.00M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CMAXW vs EPRT ($10,000, DRIP)

YearCMAXW PortfolioCMAXW Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$2,094,033$2,083,333.33$11,205$505.18+$2.08MCMAXW
2$409,957,386$407,716,770.51$12,672$682.46+$409.94MCMAXW
3$75,037,124,826$74,598,470,422.36$14,490$930.48+$75037.11MCMAXW
4$12,841,257,574,210$12,760,967,850,647.00$16,786$1,282.69+$12841257.56MCMAXW
5$2,054,684,712,278,176$2,040,944,566,673,771.00$19,753$1,791.56+$2054684712.26MCMAXW
6$307,398,888,277,703,700$305,200,375,635,566,000.00$23,677$2,541.64+$307398888277.68MCMAXW
7$43,002,429,063,308,950,000$42,673,512,252,851,814,000.00$29,008$3,672.99+$43002429063308.92MCMAXW
8$5,625,127,515,678,174,000,000$5,579,114,916,580,434,000,000.00$36,463$5,425.08+$5625127515678174.00MCMAXW
9$688,076,267,371,778,200,000,000$682,057,380,930,002,500,000,000.00$47,238$8,221.57+$688076267371778176.00MCMAXW
10$78,708,720,625,850,720,000,000,000$77,972,479,019,762,930,000,000,000.00$63,385$12,840.73+$78708720625850728448.00MCMAXW

CMAXW vs EPRT: Complete Analysis 2026

CMAXWStock

CareMax, Inc. provides chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, Tennessee, Texas, and New York. The company is headquartered in Miami, Florida.

Full CMAXW Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this CMAXW vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMAXW vs SCHDCMAXW vs JEPICMAXW vs OCMAXW vs KOCMAXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.